RecruitingPhase 2NCT04356469
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
Studying Hemoglobinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johns Hopkins All Children's Hospital
- Principal Investigator
- Deepak Chellapandian, MD, MD, MPHJohns Hopkins All Children's Hospital
- Intervention
- Haploidentical Hematopoietic Cell Transplantation(biological)
- Enrollment
- 17 enrolled
- Eligibility
- 0-21 years · All sexes
- Timeline
- 2020 – 2026
Study locations (1)
- Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04356469 on ClinicalTrials.gov